** Shares of medical equipment maker West Pharmaceutical Services rise 9.97% to $315.01 premarket
** Co raises annual adj. profit forecast to be between $6.55 and $6.75 per share vs prior range of $6.35 to $6.65 per share
** Expects full-year revenue forecast to be between $2.88 billion and $2.91 billion, up from the prior range of $2.87 billion to $2.90 billion
** Analysts, on average, were expecting annual profit of $6.51 per share and total revenue of $2.87 billion - LSEG
** Posts Q3 adj. profit of $1.85/shr vs analysts' estimates of $1.50/shr
** As of last close, stock down 18.6% YTD
(Reporting by Sruthi Narasimha Chari and Sriparna Roy in Bengaluru)
((Sruthinarasimha.chari@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.